Condition: Bladder Cancer · Sponsor: Cedars-Sinai Medical Center
To improve upon the non-invasive detection of BCa by further validating a multiplex ELISA assay directed at a BCa-associated diagnostic signature in voided urine samples of patients with microscopic hematuria.
This description comes directly from the study's public registry record.
Charles Rosser, MD · 310-423-5609 · charles.rosser@cshs.org
Always discuss trial participation with your own doctor first.
| VA Long Beach Healthcare System | Long Beach, California, United States | Recruiting |
| Cedars-Sinai Medical Center | Los Angeles, California, United States | Recruiting |
| UCLA Medical Center | Los Angeles, California, United States | Recruiting |
| Hoag Memorial Hospital Presbyterian | Newport Beach, California, United States | Recruiting |
| University of Rochester Medical Center | Rochester, New York, United States | Recruiting |
| UT Southwestern Medical Center at Dallas | Dallas, Texas, United States | Recruiting |
| Nara Prefecture Seiwa Medical Center | Nara, Nara, Japan | Recruiting |
| Nara Medical University | Nara, Japan | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT03193541